These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of glucocorticoid treatment on focal and systemic bone loss in rheumatoid arthritis. Di Munno O, Delle Sedie A. J Endocrinol Invest; 2008 Jul; 31(7 Suppl):43-7. PubMed ID: 18791351 [Abstract] [Full Text] [Related]
3. Current use of glucocorticoids in patients with rheumatoid arthritis in Germany. Thiele K, Buttgereit F, Huscher D, Zink A, German Collaborative Arthritis Centres. Arthritis Rheum; 2005 Oct 15; 53(5):740-7. PubMed ID: 16208641 [Abstract] [Full Text] [Related]
4. Screening and treatment of glucocorticoid-induced osteoporosis in rheumatoid arthritis patients in an urban multispecialty practice. Ledwich LJ, Clarke K. J Clin Rheumatol; 2009 Mar 15; 15(2):61-4. PubMed ID: 19265346 [Abstract] [Full Text] [Related]
9. Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice. Solomon DH, Katz JN, Jacobs JP, La Tourette AM, Coblyn J. Arthritis Rheum; 2002 Dec 15; 46(12):3136-42. PubMed ID: 12483716 [Abstract] [Full Text] [Related]
10. Pharmacology of glucocorticoids in rheumatoid arthritis. Spies CM, Bijlsma JW, Burmester GR, Buttgereit F. Curr Opin Pharmacol; 2010 Jun 15; 10(3):302-7. PubMed ID: 20202903 [Abstract] [Full Text] [Related]
12. [Prophylaxis of glucocorticoid-induced osteoporosis]. Tanaka Y. Clin Calcium; 2006 Nov 15; 16(11):1858-65. PubMed ID: 17079853 [Abstract] [Full Text] [Related]
13. [Clinical features of fracture with glucocorticoid induced osteoporosis and rheumatoid arthritis]. Nampei A, Hashimoto J. Clin Calcium; 2006 Nov 15; 16(11):1866-70. PubMed ID: 17079854 [Abstract] [Full Text] [Related]
14. The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis. van Staa TP. Calcif Tissue Int; 2006 Sep 15; 79(3):129-37. PubMed ID: 16969593 [Abstract] [Full Text] [Related]
15. [Modifications of markers of bone resorption in patients affected by glucocorticoid induced osteoporosis (GIOP) treated with neridronate]. Benucci M, Dolenti S, Saviola G, Manfredi M. Recenti Prog Med; 2006 Jan 15; 97(1):24-7. PubMed ID: 16535926 [Abstract] [Full Text] [Related]
16. Update on glucocorticoid-induced osteoporosis. Maricic M. Rheum Dis Clin North Am; 2011 Aug 15; 37(3):415-31, vi. PubMed ID: 22023900 [Abstract] [Full Text] [Related]
17. Safety of low- to medium-dose glucocorticoid treatment in rheumatoid arthritis: myths and reality over the years. Santiago T, da Silva JA. Ann N Y Acad Sci; 2014 May 15; 1318():41-9. PubMed ID: 24814757 [Abstract] [Full Text] [Related]
18. Glucocorticoids: action and new therapeutic insights in rheumatoid arthritis. Kirwan J, Power L. Curr Opin Rheumatol; 2007 May 15; 19(3):233-7. PubMed ID: 17414948 [Abstract] [Full Text] [Related]
20. Randomized withdrawal of long-term prednisolone treatment in rheumatoid arthritis: effects on inflammation and bone mineral density. Tengstrand B, Larsson E, Klareskog L, Hafström I. Scand J Rheumatol; 2007 May 15; 36(5):351-8. PubMed ID: 17963164 [Abstract] [Full Text] [Related] Page: [Next] [New Search]